Welcome to Lynxee consulting's blog
This blog offers you the latest regulatory news in the plant protection sector. Posts have been compiled since 2015.15 July 2016
An Opinion intended for applicants and approval holders of plant protection products and manufacturers of these products was published on 13 July 2016 in the French Official […]
15 July 2016
An Opinion intended for manufacturers, distributors and users of personal protective equipment which protect from plant protection products was published on 9 July 2016 in the French […]
5 July 2016
ANSES was seised on 26 February 2016 by DGAl (Directorate of Food of the French Ministry of Agriculture) on the need to wear personal protective equipment […]
1 July 2016
A new application form for MRL is available on Europa website. It is to be used to: Set specific maximum residue level(s) (new active substance not […]
1 July 2016
The Note DGAL/SDQPV/2016-447 of 30 May 2016 from the French Ministry of Agriculture, Food and Forestry adds new biocontrol products to the list quoted in Article […]
30 June 2016
The European Commission adopted the extension of the current approval of glyphosate until the European Chemical Agency (ECHA) has concluded its review (revision of the harmonised […]
30 June 2016
Anses has given free access to all data of e-phy website. The downloadable files contain the characteristics of each product: approval number, trade name, product type, […]
29 June 2016
As announced in February 2016, Anses had engaged a review of the marketing authorisations of plant protection products containing glyphosate and POE-tallowamine. As unacceptable risks, mainly […]
17 June 2016
The European Commission presented on 15 June 2016 draft regulations which set the criteria to identify endocrine disruptors under pesticides and biocides regulations. These drafts will […]
16 June 2016
ANSES have issued a memo summarising the requirements for: Applications for trial permits (replacing ‘ADE’), including: Exemption from trial permit applications Preliminary declaration of trials Exemption […]